Search for: "Amneal Pharmaceuticals Inc" Results 1 - 20 of 46
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Apr 2024, 1:07 pm by Bevin Newman
The Federal Trade Commission (“FTC”) has filed an amicus brief in Teva Branded Pharmaceuticals Products R&D, Inc. v. [read post]
26 Mar 2024, 7:01 pm by Kurt R. Karst
  Late last week, the FTC submitted an Amicus Brief in recent Hatch-Waxman patent litigation in the District Court of New Jersey between Reference Listed Drug holder Teva Branded Pharmaceutical Products R&D Inc. and ANDA applicant Amneal Pharmaceuticals explaining that patents that claim the device constituent of a combination product but do not expressly claim the relevant drug substance should not be listed in the Orange Book. [read post]
20 Jul 2020, 10:53 am by Matthew L.M. Fletcher
Amneal Pharmaceuticals, LLC (Opioid Manufacturing) U.S. [read post]
15 Jul 2020, 1:56 pm by Unknown
Amneal Pharmaceuticals, LLC (Opioid Manufacturing) U.S. [read post]
16 Jun 2020, 9:59 pm by Patent Docs
Amneal Pharmaceuticals LLC) and its related limiting doctrines, prosecution history estoppel (Amgen Inc. v. [read post]
11 May 2020, 9:59 pm by Patent Docs
Amneal Pharmaceuticals LLC") is most frequently rebutted by the doctrine of prosecution history estoppel ("Pharma Tech Solutions, Inc. v. [read post]
15 Apr 2020, 7:54 am by Dennis Crouch
Amneal Pharmaceuticals LLC. [read post]
17 Mar 2020, 1:32 pm by Noble McIntyre
Eco-Gel 200 ultrasound gel has been recalled by Eco-Med Pharmaceutical, Inc. due to bacterial contamination. [read post]
13 Jul 2018, 5:54 pm by Lawrence B. Ebert
The outcome:Jazz Pharmaceuticals, Inc. [read post]
30 Apr 2018, 10:30 am by Doyle, Barlow & Mazard PLLC
On April 27, 2018, the FTC announced that Amneal Pharmaceuticals LLC (“Amneal”) may complete its acquisition of an equity share in Impax Laboratories Inc. [read post]
30 Apr 2018, 10:30 am by Doyle, Barlow & Mazard PLLC
On April 27, 2018, the FTC announced that Amneal Pharmaceuticals LLC (“Amneal”) may complete its acquisition of an equity share in Impax Laboratories Inc. [read post]
7 Dec 2017, 9:34 pm by Patent Docs
Seeking approval to market generic versions of Eli Lilly's Axiron® testosterone applicator, Defendants Perrigo Company and Perrigo Israel Pharmaceuticals Ltd., Actavis Laboratories UT, Inc., FKA Watson Laboratories Inc., Lupin Pharmaceuticals, Inc. and Lupin Ltd., and Amneal Pharmaceuticals LLC filed... [read post]